PUBLIC COMPANY
save$COLLCOLLEGIUM PHARMACEUTICAL, INC
$COLL27.20-7.70%Stoughton, MA, USupdated 7h ago
community read0 votes
pipeline
6
marketed
3
phase 3
0
catalysts ytd
14
approvals ytd
11
recalls ytd
0
Pipeline(6)
pipeline depth6 products
3Marketed3Unknown
Marketed
methylphenidate hydrochloride ER
Attention Deficit Hyperactivity Disorder (ADHD)
Marketedoxycodone ER
Pain
Marketedtapentadol hydrochloride ER
Diabetic Neuropathic Pain
drugNUCYNTA
1 INDICATIONS AND USAGE NUCYNTA (tapentadol) tablets are…
Sodium-dependent noradrenaline transporterMu-type opioid receptor
drugNUCYNTA ER
1 INDICATIONS AND USAGE NUCYNTA ER (tapentadol) is indica…
Sodium-dependent noradrenaline transporterMu-type opioid receptor
drugXTAMPZA ER
1 INDICATIONS AND USAGE XTAMPZA ER is indicated for the m…
Mu-type opioid receptor
Upcoming
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (1)
- Mar 17, 26tax coverDieter David · EVP & General Counsel8,840 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that